Capital Investment Advisory Services, LLC Bluebird Bio, Inc. Transaction History

Capital Investment Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$46.96 - $61.67 $4,696 - $6,167	-100 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$59.47 - $93.1 $5,947 - $9,310	-100 Reduced 50.0%	100 $9,000
Q2 2019 Aug 08, 2019	BUY	$75.84 - $105.21 $7,584 - $10,521	100 Added 100.0%	200 $28,000
Q1 2019 Apr 23, 2019	BUY	$64.44 - $104.11 $6,444 - $10,411	100 New	100 $16,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.